Mylan Asi Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN ASI, and what generic and branded alternatives to MYLAN ASI drugs are available?
MYLAN ASI has six approved drugs.
Drugs and US Patents for Mylan Asi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Asi | GRANISETRON HYDROCHLORIDE | granisetron hydrochloride | INJECTABLE;INJECTION | 091136-001 | Apr 9, 2010 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Asi | ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 090212-002 | Mar 28, 2014 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Asi | AZITHROMYCIN | azithromycin | INJECTABLE;INJECTION | 065506-001 | Mar 24, 2009 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.